Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Medscape - A Stepwise  Approach To Managing HR+/HER2- Early Breast Cancer: From Risk Assessment To Risk Management 

How would you manage this patient with HR-positive/HER2-negative EBC? A Live Test and Teach Session

Date

17 Sep 2021

Session

Medscape - A Stepwise  Approach To Managing HR+/HER2- Early Breast Cancer: From Risk Assessment To Risk Management 

Presenters

Miguel Martin

Authors

J. O'Shaughnessy1, V. Guarneri2, M. Martin3

Author affiliations

  • 1 Texas Oncology - Baylor Sammons Cancer Center, 75246 - Dallas/US
  • 2 Department Of Surgery, Oncology And Gastroenterology Dept., University of Padua, 35122 - Padova/IT
  • 3 Medical Oncology Service, Instituto de Investigacion Sanitaria Gregorio Marañon, CIBERONC, Universidad Complutense and GEICAM, Madrid/ES

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.